Purpose of the study
This is an observational surveillance study to evaluate pregnancy outcomes in pregnant women who have taken asthma medications or received influenza vaccine during pregnancy. In one arm of the study, performed by the Organization of Teratology Information Specialists (OTIS), participants will take part in a telephone interview each trimester and after delivery. No clinic visits are required. VAMPSS is coordinated by the American Academy of Allergy Asthma & Immunology (AAAAI).

Eligible participants

·     Women who are pregnant AND

·     Who have taken a long-acting beta agonist (Foradil, Serevent, Advair, Dulera, Symbicort) or short-acting beta agonist (e.g. albuterol) or received influenza vaccine anytime in pregnancy

Principal investigator
Christina Chambers, PhD, MPH
University of California San Diego, San Diego, CA

For more information or to enroll
Call 877-311-8972

Visit www.otispregnancy.org/

Updated posting November 2012